Sanofi eyes Covid-19 vaccine approval in early 2021; partners Translate Bio

French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential Covid-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.

Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second half of 2021. "We are being guided by our dialogue with regulatory authorities," Sanofi research chief John Reed told reporters, when asked.....

This article is no longer available in our repository.

There could be multiple reasons for this.